Market closed· · EUR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Formycon AG (WBO:FYB) reports a significant revenue surge and improved EBITDA, driven by commercial momentum and strategic partnerships.
MUNICH, GERMANY and BANGALORE, INDIA - July 14, 2026 (NEWMEDIAWIRE) - Formycon AG (FSE: FYB, Prime Standard, "Formycon") and OneSource Specialty Pharma Limited (BSE: 544292, NSE: ONESOURCE, "OneSource"), a multi-modality specialty pharma CDMO, tod...
As European markets navigate the complexities of geopolitical developments and economic shifts, such as the ongoing U.S.-Iran negotiations and supply chain challenges, investors are increasingly focused on identifying growth opportunities within the region. In this environment, companies with high insider ownership can offer potential advantages, as they often align management's interests with those of shareholders, fostering long-term growth strategies amidst market uncertainties.
Formycon AG (WBO:FYB) reports robust revenue growth and strategic product launches, while navigating cash flow and cost management hurdles.
As European markets navigate a complex landscape of stalled geopolitical negotiations and fluctuating oil prices, the pan-European STOXX Europe 600 Index has remained largely stable with slight positive momentum in corporate earnings. In this environment, stocks with high insider ownership can be particularly attractive to investors seeking growth opportunities, as they often indicate strong alignment between company leadership and shareholders' interests.
The analysts covering Formycon AG ( ETR:FYB ) delivered a dose of negativity to shareholders today, by making a...
Despite revenue setbacks, Formycon AG (XTER:FYB) exceeded EBITDA expectations and set a positive outlook for 2026 with strategic initiatives and geographic diversification.
PLANEGG-MARTINSRIED, GERMANY - April 20, 2026 (NEWMEDIAWIRE) - Formycon AG (FSB: FYB, Prime Standard, "Formycon") plans to publish its results of the financial year 2025 on April 22, 2026. The Management Board will discuss the company's developmen...
As European markets continue to show resilience, with the pan-European STOXX Europe 600 Index reaching new highs and optimism about the eurozone economy bolstering investor sentiment, opportunities may arise for investors seeking stocks potentially priced below their estimated value. In this context, identifying undervalued stocks involves looking for companies that demonstrate strong fundamentals yet have not fully reflected these in their current market valuations amidst ongoing market...
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.